Controlant BioSample Monitoring

To ensure the integrity of biological samples during transportation to the testing lab, Controlant BioSample Monitoring helps avoid or mitigate errors such as:

delayed transportation
incorrect storage and transportation

Biological samples are usually chilled or frozen to maintain integrity before testing. Sample integrity is critical as the majority of errors occur during the pre-analytical phase, before any specimen arrives at the lab.

Up to 70% of all medical decisions are based on a pathology or laboratory result. Lab tests provide essential information that helps healthcare professionals make informed decisions about diagnosis, treatment, and monitoring of various conditions.

Use case

Collecting and delivering biomedical samples to respective labs is time-sensitive and challenging. Ensuring sample viability and safety on-the-go is crucial when you only have one chance at delivery

Outcome

Our solution enhances sample management, reducing the risk of damaged samples and saving both time and costs. It boosts efficiency in clinical trials while providing greater visibility into sample routes, driver utilization, and overall operational performance.

Pain points

Drivers often face challenges due to the lack of real-time in-transit notifications during multi-stop collection routes. Monitoring the temperature of different boxes — whether cold, ambient, or dry ice — and accurately tracking and reconciling thousands of samples also presents significant difficulties.

Solution

A mobile app allows drivers to scan biomedical samples into the correct temperature box and monitor them during transit. It provides real-time alerts for temperature boundary breaches and supports both automatic and manual report generation and distribution.

Clinical biological sample management

Ensuring the sample integrity is critical within the clinical trial setting
Samples are always taken in duplicate and sent to the lab separately
These can count into tens or even hundreds of thousands of samples in a single clinical trial

Direct cost impact of lost or damaged biological samples

Billions of biological samples are collected annually for diagnostic, research, and medical purposes across the world.
Costly delays in clinical trials can impact data integrity and new treatment availability to patients.

It is estimated that between 1 and 5% of samples are spoilt or lost before the samples reach the testing lab

Equals about 240-400 million samples lost globally each year
Direct impact on cost where re-sampling and re-testing is required
Indirect cost of delayed diagnoses and potential increased treatment costs